Research have engineered biohybrid nerve tissue -- containing both living cells and non-living components -- to develop 3D models of neural networks, an advance that may lead to better understanding of how the brain works.
The researchers, including Gelson Pagan-Diaz from the University of Illinois in the US, said the produced tissue is similar to a computer processing unit, which provided the basic principle to today's supercomputers.
The study, published in the journal PNAS, noted that the 3D tissue, consisting of neurons, can provide the ability to develop tissue models for drug screening, or processing units for biological computers.
The researchers said using a 3D model of these networks outside the body may offer researchers a new tool to understand how these connections work.
These models, they said, can help shed light on how abnormalities form such as what gives rise to diseases such as Alzheimer's.
According to the researchers, the 3D tissues can be used to study complex behaviours that happen in the brain, and how these tissues react with new drugs being developed.
It may lead to less reliance on animals to test these drugs in the future, they said.
The scientists said, these tissues can also be programmed to be activated using blue light, in a field of study called optogenetics.
"If we can control how these neurons communicate with each other, if we can train them using optogenetics, if we can program them, then we can potentially use to perform engineering functions. In the future, our hope is that by being able to design these neural tissue, we can begin to realize biological processing units and biological computers, similar to the brain," said study co-author Rashid Bashir from the University of Illinois.
In the current study, the scientists developed neural tissue that can form different shapes, using hydrogels and a protein called fibrin to make millimetre to centimeter scale structures.
They said these structures don't have rigid scaffolds and can be molded into a number of desired shapes.
"It's a bundle of hundreds to thousands of microns of cells that contains a lot of populations with a genetic makeup similar to in vivo tissues," Pagan-Diaz explained.
With new techniques for developing these tissues, the researchers said they can capture a lot of the phenomena happening in the neurons in vivo.
"Once we can prove that, we will be able to mimic the morphology that we see in the brain. Once we show that the tissue engineered outside the body is similar to the tissue in the body, then we can then fabricate them over and over again," Pagan-Diaz said.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)